Brainstorm
FDA Skeptical of Experimental ALS Treatment Pushed by Patient Advocates
2023-09-25 15:41:28
by
FDA Skeptical of Experimental ALS Treatment Pushed by Patient Advocates
WASHINGTON (AP) — The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant... Read More
Straight From The Well
